MD Anderson Cancer Center ( Site 0001)

Houston, Texas 77030

0 studies enrolling now · 2 studies all time

What they study most

Acute Lymphoid Leukemia, Acute Myeloid Leukemia, Burkitt Lymphoma, Chronic Lymphocytic Leukemia, Diffuse Large B-cell Lymphoma, Follicular Lymphoma, Lymphoplasmacytoid Lymphoma, Mantle Cell Lymphoma, Marginal Zone Lymphoma, Neoplasm Metastasis, Richter Transformation Lymphoma, T-cell Non-Hodgkin Lymphoma

Studies at this site

• A Study of Intratumoral/Intralesional Administration of V938 in Combination With Pembrolizumab (MK-3475) in Participants With Advanced/Metastatic or Recurrent Malignancies (V938-001) — Stopped early
• A Study of Zilovertamab Vedotin (MK-2140) (VLS-101) in Participants With Hematologic Malignancies (MK-2140-001) — Completed